Drugs
How we treat inflammation may be causing chronic pain
Reversing common belief, researchers at McGill say treating inflammation may be causing chronic pain, not preventing it.
‘Mad honey’: The rare hallucinogen from the mountains of Nepal
On the mountainsides of Nepal and Turkey, bees sometimes produce a strange and dangerous concoction: mad honey.
AI maps psychedelic “trip” experiences to regions of the brain – opening new route to psychiatric treatments
To better understand how these effects manifest in the brain, we analyzed over 6,000 written testimonials of hallucinogenic experiences.
How the antidepressant Prozac could treat blindness
Prozac is a widely used antidepressant. Data indicates that the drug could be used to prevent blindness due to macular degeneration.
90% of drugs fail clinical trials – here’s one way researchers can select better drug candidates
It’s disappointing when the years of effort and resources spent to push a drug candidate to patients so often lead to failure.
Opioid overdose: A bioethicist explains why restricting supply may not be the right solution
Since the unpredictability of drug supply increases overdose risk, making the drug supply predictable should be part of the solution, right?
Horseshoe crabs are drained for their blue blood. That practice will soon be over.
One of humanity’s strangest and most macabre activities is slowly coming to an end, a trend that every horseshoe crab should celebrate.
Harm reduction vending machines are coming to New York
New York City has announced a pilot program installing public health vending machines with overdose drugs and clean needles.
Ketamine therapy may help former drinkers stay abstinent
A new study has found evidence that ketamine, combined with therapy, can help people with alcohol addiction abstain longer.
Morning glories may be a source of new psychedelics and medicines
Researchers have found that the symbiotic relationship between a fungus and a morning glory holds the potential for new psychedelic compounds and medicines.